Mycetoma caused by Trichosporon asteroids-report of the first case
DOI:
https://doi.org/10.18203/2320-6012.ijrms20233044Keywords:
Mycetoma, Trichosporon asteroids, First caseAbstract
Mycetoma is a neglected disease that affects mainly the skin, but can progress to deep tissues and structures such as muscles and bones. Mycetoma can be caused by some bacterial (actinomycetoma) or fungal species (eumycetoma); furthermore, eumycetoma is estimated to account for 40% of all cases of mycetomas. Regardless of etiology, human infections occur after accidental implantation of etiological agents through the skin. In the present work, an immunocompetent patient without systemic comorbidity is reported to have exhibited a progressive increase of the left foot with multiple fistulas in the dorsum in the last 15 years, which emerged as a purulent secretion in the presence of yellowish grains. The patient reported that during a trip she suffered injuries in the affected foot. Histopathological study showed the presence of fungal grains, and the culture of skin fragments allowed the identification of fungal colonies exhibiting a dry, cream-coloured cerebriform morphology with a radiated peripheral edge. The micromorphology examination of the isolate demonstrated the presence of hyphae that swell and become multiseptate, budding cells, and lateral conidia were absent. MALD-TOF MS analysis led to the identification of Trichosporon asteroides as etiologic. Different treatment regimens were performed with no success, moderate improvement was observed with voriconazole, and treatment is still ongoing. This is the first case report to incriminate T. asteroides as an etiological agent of eumycetoma.
Metrics
References
Verma P, Jha A. Mycetoma: reviewing a neglected disease. Clin Exp Dermatol. 2019;44(2):123-9.
Cathrine AN, Bhattacharya K, Srinivasan V. Mycetoma leg a-case report. Int J Low Extrem Wounds. 2003;2(3):171-2.
De Palma L, Marinelli M, Pavan M, Manso E, Ranaldi R. A rare European case of Madura Foot due to actinomycetes. J Bone Spine. 2006;73(3):321-4.
Venkatswami S, Sankarasubramanian A, Subramanyam S. The madura foot: looking deep. Int J Low Extrem Wounds. 2012;11(1):31-42.
Verma P, Jha A. Mycetoma: reviewing a neglected disease. Clin Exp Dermatol. 2019;44(2):123-9.
Estrada R, Chávez-López G, Estrada-Chávez G, López-Martínez R, Welsh O. Eumycetoma Clin Dermatol. 2012;30(4):389-96.
Husain U, Verma P, Suvirya S, Priyadarshi K, Gupta P. An overview of mycetoma and its diagnostic dilemma: Time to move on to advanced techniques. Indian J Dermatol Venereol Leprol. 2023;89(1):12-7.
Seas C, Legua P. Mycetoma, chromoblastomycosis and other deep fungal infections: diagnostic and treatment approach. Curr Opin Infect Dis. 2022;35(5):379-83.
Lichon V, Khachemoune A. Mycetoma : a review. Am J Clin Dermatol. 2006;7(5):315-21.
Belda W, Criado PR, Passero DLF. Botryomycosis in patient with pituitary microadenome: A case report. Dermatol. Ther. 2020;33(4):e13529.
Belda W, Domingues Passero LF, Stradioto Casolato AT. Lymphocutaneous Sporotrichosis Refractory to First-Line Treatment. Case Rep Dermatol Med. 2021;2021:9453701.
Belda W, Criado PR, Passero DLF. Successful treatment of chromoblastomycosis caused by Fonsecaea pedrosoi using imiquimod. J Dermatol. 2020;47(4):409-12.
Ahmed AA, Van de Sande W, Fahal AH. Mycetoma laboratory diagnosis: Review article. PLoS Negl. Trop. Dis. 2017;11(8):e0005638.
Musa EA, Abdoon IH, Bakhiet SM, Osman B, Abdalla SA, Fahal AH. Mycetoma management and clinical outcomes: the Mycetoma Research Center experience. Trans R Soc Trop Med Hyg. 2023;117(1):12-21.
Singh A, Singh PK, Kumar A, Chander J, Khanna G, Roy P et al. Molecular and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry-Based Characterization of Clinically Significant Melanized Fungi in India. J Clin Microbiol. 2017;55(4):1090-103.
Fraser M, Borman AM, Johnson EM. Rapid and Robust Identification of the Agents of Black-Grain Mycetoma by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry. J Clin Microbiol. 2017;55(8):2521-8.
Emery D, Denning DW. The global distribution of actinomycetoma and eumycetoma. PLoS Negl Trop Dis. 2020;14(9):e0008397.
Fahal AH, Ahmed KO, Saeed AA, Elkhawad AO, Bakhiet SM. Why the mycetoma patients are still neglected. PLoS Negl Trop Dis. 2022;16(12):e0010945.
Agarwal P, Jagati A, Rathod SP, Kalra K, Patel S, Chaudhari M. Clinical Features of Mycetoma and the Appropriate Treatment Options. Res Rep Trop Med. 2021;12:173-9.
Passero LFD, Cavallone IN, Belda W. Reviewing the Etiologic Agents, Microbe-Host Relationship, Immune Response, Diagnosis, and Treatment in Chromoblastomycosis. J Immunol Res. 2021;2021:1-23.
Yamamoto ES, De Jesus JA, Bezerra-Souza A, Brito JR, Lago JHG, Laurenti MD et al. Tolnaftate inhibits ergosterol production and impacts cell viability of Leishmania sp. Bioorg Chem. 2020;102:104056.
Welsh O, Al-Abdely HM, Salinas-Carmona MC, Fahal AH. Mycetoma Medical Therapy. PLoS Negl Trop Dis. 2014;8(10):e3218.
Welsh O, Vera-Cabrera L, Welsh E, Salinas MC. Actinomycetoma and advances in its treatment. Clin Dermatol. 2012;30(4):372-81.
Zijlstra EE, Van de Sande WWJ, Welsh O, Mahgoub ES, Goodfellow M, Fahal AH. Mycetoma: a unique neglected tropical disease. Lancet Infect Dis. 2016;16(1):100-12.
Suleiman SH, Wadaella E, Fahal AH. The Surgical Treatment of Mycetoma. PLoS Negl Trop Dis. 2016;10(6):e0004690.
Mohamed ESW, Bakhiet SM, El Nour M, Suliman SH, El Amin HM, Fahal AH. Surgery in mycetoma-endemic villages: unique experience. Trans R Soc Trop Med Hyg. 2021;115(4):320-23.
Roopavathana SB, Samarasam I, Thomas CT, Chase S, Nayak S. Role of surgery in the management of mycetoma foot. Int Surg J. 2018;6:78.
De Almeida Júnior JN, Figueiredo DSY, Toubas D, Del Negro GMB, Motta AL, Rossi F et al. Usefulness of matrix-assisted laser desorption ionisation-time-of-flight mass spectrometry for identifying clinical Trichosporon isolates. Clin Microbiol Infect. 2014;20(8):784-90.
De Almeida JN, Favero Gimenes VM, Francisco EC, Machado Siqueira LP, Gonçalves de Almeida RK, Guitard J, Hennequin C et al. Evaluating and Improving Vitek MS for Identification of Clinically Relevant Species of Trichosporon and the Closely Related Genera Cutaneotrichosporon and Apiotrichum. J Clin Microbiol. 2017;55(8):2439-44.
Reis CMS, Reis-Filho EGM. Mycetomas: an epidemiological, etiological, clinical, laboratory and therapeutic review. An Bras Dermatol. 2018;93(1):8-18.
Van de Sande WWJ. Global burden of human mycetoma: a systematic review and meta-analysis. PLoS Negl. Trop Dis. 2013;7(11):e2550.
Dieng MT, Sy MH, Diop BM, Niang SO, Ndiaye B. Mycetoma: 130 cases. Ann Dermatol Venereol. 2003;130(1 pt 1):16-9.
Marill FG, Timsit E. Mycetoma of foot caused by Actinomyces israeli treated by a combination of streptomycin and a sulfone derivative. Bull Soc Fr Dermatol Syphiligr. 1957;64(5):689-90.
Ahmed SA, Van de Sande WWJ, Stevens DA, Fahal A, Van Diepeningen AD, Menken SB et al. Revision of agents of black-grain eumycetoma in the order Pleosporales. Persoonia. 2014;33:141-54.
Bieber AK, Pomeranz MK, Kim RH. White Piedra. JAMA Dermatol. 2021;157(3):339.
Noguchi H, Matsumoto T, Kimura U, Hiruma M, Kano R, Yaguchi T et al. Onychomycosis caused by Trichosporon cacaoliposimilis. J Dermatol. 2020;47(5):e193-5.
Lo C, Kang CL, Sun P-L, Yu PH, Li WT. Disseminated Fungal Infection and Fungemia Caused by Trichosporon asahii in a Captive Plumed Basilisk (Basiliscus plumifrons). J Fungi (Basel, Switzerland). 2021;7(12):1003.
Kustimur S, Kalkanci A, Caglar K, Dizbay M, Aktas F, Sugita T. Nosocomial fungemia due to Trichosporon asteroides: firstly described bloodstream infection. Diagn Microbiol Infect Dis. 2002;43:167-70.
Downloads
Published
How to Cite
Issue
Section
